These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16136394)

  • 1. A renewed appreciation for ocular immune privilege.
    Niederkorn JY
    Arch Soc Esp Oftalmol; 2005 Aug; 80(8):437-8; 439-40. PubMed ID: 16136394
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of complement system in ocular diseases including uveitis and macular degeneration.
    Jha P; Bora PS; Bora NS
    Mol Immunol; 2007 Sep; 44(16):3901-8. PubMed ID: 17768108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement, innate immunity and ocular disease.
    Sohn JH; Bora PS; Jha P; Tezel TH; Kaplan HJ; Bora NS
    Chem Immunol Allergy; 2007; 92():105-114. PubMed ID: 17264487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement regulation in the eye: implications for age-related macular degeneration.
    Wilke GA; Apte RS
    J Clin Invest; 2024 May; 134(9):. PubMed ID: 38690727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The link between morphology and complement in ocular disease.
    Mohlin C; Sandholm K; Ekdahl KN; Nilsson B
    Mol Immunol; 2017 Sep; 89():84-99. PubMed ID: 28622910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Can complement blocking arrest peritoneal fibrosis?].
    Esposito V
    G Ital Nefrol; 2010; 27(1):8. PubMed ID: 20191454
    [No Abstract]   [Full Text] [Related]  

  • 7. The complement system and age-related macular degeneration.
    Sivaprasad S; Chong NV
    Eye (Lond); 2006 Aug; 20(8):867-72. PubMed ID: 16410816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement Inhibitors in Age-Related Macular Degeneration: A Potential Therapeutic Option.
    Qin S; Dong N; Yang M; Wang J; Feng X; Wang Y
    J Immunol Res; 2021; 2021():9945725. PubMed ID: 34368372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The case for complement and inflammation in AMD: open questions.
    Karagianni N; Adamis AP
    Adv Exp Med Biol; 2010; 703():1-7. PubMed ID: 20711703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement depletion with humanised cobra venom factor: efficacy in preclinical models of vascular diseases.
    Vogel CW; Fritzinger DC; Gorsuch WB; Stahl GL
    Thromb Haemost; 2015 Mar; 113(3):548-52. PubMed ID: 25031089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected and novel functions of complement proteins.
    Herwald H; Egesten A
    J Innate Immun; 2014; 6(4):405-6. PubMed ID: 24853386
    [No Abstract]   [Full Text] [Related]  

  • 12. Complement system and age-related macular degeneration: drugs and challenges.
    Wu J; Sun X
    Drug Des Devel Ther; 2019; 13():2413-2425. PubMed ID: 31409975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological non-responsiveness and acquisition of tolerance in relation to immune privilege in the eye.
    Streilein JW
    Eye (Lond); 1995; 9 ( Pt 2)():236-40. PubMed ID: 7556724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement in kidney disease: core curriculum 2015.
    Thurman JM
    Am J Kidney Dis; 2015 Jan; 65(1):156-68. PubMed ID: 25441433
    [No Abstract]   [Full Text] [Related]  

  • 15. Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation.
    Streilein JW
    J Leukoc Biol; 2003 Aug; 74(2):179-85. PubMed ID: 12885934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The eye as a complement dysregulation hotspot.
    Clark SJ; Bishop PN
    Semin Immunopathol; 2018 Jan; 40(1):65-74. PubMed ID: 28948331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between the complement system, risk factors and prediction models in age-related macular degeneration.
    Bora NS; Matta B; Lyzogubov VV; Bora PS
    Mol Immunol; 2015 Feb; 63(2):176-83. PubMed ID: 25074023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement activation and inhibition: a delicate balance.
    Sjöberg AP; Trouw LA; Blom AM
    Trends Immunol; 2009 Feb; 30(2):83-90. PubMed ID: 19144569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interrelation Between Oxidative Stress and Complement Activation in Models of Age-Related Macular Degeneration.
    Pujol-Lereis LM; Schäfer N; Kuhn LB; Rohrer B; Pauly D
    Adv Exp Med Biol; 2016; 854():87-93. PubMed ID: 26427398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Privilege revisited: an evaluation of the eye's defence mechanisms.
    Forrester JV
    Eye (Lond); 2009 Apr; 23(4):756-66. PubMed ID: 18989350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.